Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Microbiol ; 56(8): 586-592, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-30047088

RESUMO

The emergence of oseltamivir-resistant variants of influenza virus has highlighted the necessity for the development of more effective novel antiviral drugs. To date, numerous researchers have focused on developing antiviral drugs using natural resources, such as traditional herbal medicines. Poncirus trifoliata is widely used in oriental medicine as a remedy for gastritis, dysentery, inflammation and digestive ulcers. In this study, we investigated the potential antiviral effect of the Poncirus trifoliata orange seed extract against influenza virus. An ethanol extract of Poncirus trifoliata seeds (PTex) inhibited the activity of influenza viruses, in particular, oseltamivir- resistant strains, in Madin-Darby canine kidney cells. In contrast to oseltamivir, PTex exerted a significant inhibitory effect on the cellular penetration pathway of the virus rather than HA receptor binding. The potent antiviral effect and novel working mechanism of PTex support its further development as an effective natural antiviral drug with a wide spectrum of activity against influenza and oseltamivir-resistant viruses.


Assuntos
Antivirais/farmacologia , Orthomyxoviridae/efeitos dos fármacos , Extratos Vegetais/farmacologia , Poncirus/química , Animais , Antivirais/isolamento & purificação , Cães , Células Madin Darby de Rim Canino , Orthomyxoviridae/fisiologia , Extratos Vegetais/isolamento & purificação , Sementes/química , Internalização do Vírus/efeitos dos fármacos
2.
J Parasitol Res ; 2015: 361021, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26527362

RESUMO

To confirm that Korean Food and Drug Administration (KFDA) guidelines are applicable to test the efficacy of mosquito repellents, these guidelines were used to test the efficacy and complete protection times (CPTs) of three representative mosquito repellents: N,N-diethyl-3-methylbenzamide (DEET), citronella, and fennel oil. The repellency of citronella oil decreased over time, from 97.9% at 0 h to 71.4% at 1 h and 57.7% at 2 h, as did the repellency of fennel oil, from 88.6% at 0 h to 61.2% at 1 h and 47.4% at 2 h. In contrast, the repellency of DEET remained over 90% for 6 h. The CPT of DEET (360 min) was much longer than the CPTs of citronella (10.5 min) and fennel oil (8.4 min). These results did not differ significantly from previous findings, and hence confirm that the KFDA guidelines are applicable for testing the efficacy of mosquito repellents.

3.
J Microbiol ; 53(5): 348-53, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25935307

RESUMO

Studies of the retroviruses have focused on the specific interaction of the nucleocapsid protein with a packaging signal in the viral RNA as important for this selectivity, but the packaging signal in porcine endogenous retrovirus (PERV) has not been defined. Herein, we identified and analyzed this packaging signal in PERV and found hairpin structures with conserved tetranucleotides in their loops and nucleocapsid recognition sequences; both of which are key elements in the viral packaging signal of MLV. We evaluated packaging efficiency of sequence variants isolated from viral and proviral integrated genomes. All viral packaging sequences (Ψ) were identical, while five distinct packaging sequences were identified from proviral sources. One proviral sequence (Ψ1) was identical to that of the viral Ψ and had the highest packaging efficiency. Three variants (Ψ2, Ψ3, Ψ4) maintained key elements of the viral packaging signal, but had nucleotide replacements and consequently demonstrated reduced packaging efficiency. Despite of the same overall hairpin structure, the proviral variant (Ψ5) had only one GACG sequence in the hairpin loop and showed the lowest packaging efficiency other than ∆Ψ, in which the essential packaging sequence was removed. This result, thus, defined the packaging sequences in PERV and emphasized the importance of nucleotide sequence and RNA structure in the determination of packaging efficiency. In addition, we demonstrate efficient infection and gene expression from the PERV based viral vector, which may serve as a novel alternative to current retroviral expression systems.


Assuntos
Retrovirus Endógenos/genética , Retrovirus Endógenos/fisiologia , Vetores Genéticos , RNA Viral/genética , Montagem de Vírus , Regiões 5' não Traduzidas , Animais , Sequência de Bases , Conformação de Ácido Nucleico , Plasmídeos , Provírus/genética , RNA Viral/química , Alinhamento de Sequência , Análise de Sequência de DNA , Suínos
4.
J Microbiol ; 53(6): 415-20, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26025174

RESUMO

Cervical cancer is strongly associated with chronic human papillomavirus infections, among which HPV16 is the most common. Two commercial HPV vaccines, Gardasil and Cervarix are effective for preventing HPV infection, but cannot be used to treat existing HPV infections. Previously, we developed a human endogenous retrovirus (HERV)-enveloped recombinant baculovirus capable of delivering the L1 genes of HPV types 16, 18, and 58 (AcHERV-HP16/18/58L1, AcHERV-HPV). Intramuscular administration of AcHERVHPV vaccines induced a strong cellular immune response as well as a humoral immune response. In this study, to examine the therapeutic effect of AcHERV-HPV in a mouse model, we established an HPV16 L1 expressing tumor cell line. Compared to Cervarix, immunization with AcHERVHPV greatly enhanced HPV16 L1-specific cytotoxic T lymphocytes (CTL) in C57BL/6 mice. Although vaccination could not remove preexisting tumors, strong CTL activity retarded the growth of inoculated tumor cells. These results indicate that AcHERV-HPV could serve as a potential therapeutic DNA vaccine against concurrent infection with HPV 16, 18, and 58.


Assuntos
Proteínas do Capsídeo/imunologia , Carcinoma/terapia , Portadores de Fármacos , Retrovirus Endógenos/genética , Proteínas Oncogênicas Virais/imunologia , Infecções por Papillomavirus/terapia , Vacinas contra Papillomavirus/uso terapêutico , Vacinas de DNA/uso terapêutico , Animais , Proteínas do Capsídeo/genética , Modelos Animais de Doenças , Camundongos Endogâmicos C57BL , Proteínas Oncogênicas Virais/genética , Vacinas contra Papillomavirus/genética , Vacinas contra Papillomavirus/imunologia , Linfócitos T Citotóxicos/imunologia , Resultado do Tratamento , Vacinas de DNA/genética , Vacinas de DNA/imunologia
5.
Korean J Food Sci Anim Resour ; 35(3): 293-8, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26761842

RESUMO

Porcine placenta extract (PPE) is known to possess anti-inflammatory properties owing to its high concentration of bioactive substances. However, the need to eliminate blood-borne infectious agents while maintaining biological efficacy raises concerns about the optimal method for sterilizing PPE. Therefore, the objective of this study was to compare the effects of the standard pressurized heat (autoclaving) method of sterilization with γ-irradiation on the anti-inflammatory effects of PPE. The anti-inflammatory actions of these two preparations of PPE were evaluated by measuring their inhibitory effects on the production of NO, the expression of iNOS protein, and the expression of iNOS, COX2, TNF-α, IL-1ß, and IL-6 mRNA in lipopolysaccharide-stimulated RAW 264.7 cells. Compared with autoclaved PPE, γ-irradiated PPE showed significantly greater inhibition of NO production and iNOS protein expression, and produced a greater reduction in the expression of iNOS, COX2, TNF-α, IL-1ß, and IL-6 mRNA. These results provide evidence that the sterilization process is crucial in determining the biological activity of PPE, especially its anti-inflammatory activity. Collectively, our data suggest that γ-irradiated PPE acts at the transcriptional level to effectively and potently suppresses the production of NO and the expression of pro-inflammatory cytokines.

6.
J Med Entomol ; 51(1): 182-8, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24605468

RESUMO

Estimation of the efficacy of mosquito repellents requires both laboratory and field tests. The results of field tests are more meaningful, but the safety of volunteers in such tests may be a significant concern. In the current study, we compared tests of mosquito repellent efficacy under semifield conditions in an outdoor enclosure with those under laboratory and field conditions. In this study, we assessed the efficacy of N,N-diethyl-meta-toluamide under laboratory conditions with human volunteers and under semifield and field conditions with Centers for Disease Control and Prevention traps and experimental mice. A semifield test may be a suitable replacement for the more difficult field test for assessment of mosquito repellent efficacy. Semifield tests should be considered when developing new guidelines for testing.


Assuntos
Repelentes de Insetos , Aedes , Animais , DEET , Feminino , Humanos , Camundongos
7.
Anim Biotechnol ; 22(4): 175-80, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22132811

RESUMO

Here, we report the quantification of porcine endogenous retrovirus (PERV) copy numbers using real time PCR. After generating standard curves using plasmid DNA, copy numbers were determined for PERV pol and for a housekeeping gene, porcine estrogen receptor2 (ER2) with the same amount of genomic DNA. Using this method, we examined 6 pig breeds in Korea including two breeds of miniature pig, one domestic pig from Jeju, and imported pig breeds, Duroc, Landrace, and Yorkshire. All breeds showed PERV copy numbers ranging from 9 to 50. This method will be useful for monitoring of PERVs in a porcine xenograft.


Assuntos
DNA/análise , DNA/genética , Retrovirus Endógenos/isolamento & purificação , Dosagem de Genes , Reação em Cadeia da Polimerase em Tempo Real/métodos , Animais , DNA/química , DNA/isolamento & purificação , DNA Viral/análise , Retrovirus Endógenos/genética , Suínos , Porco Miniatura
8.
Vaccine ; 28(6): 1613-9, 2010 Feb 10.
Artigo em Inglês | MEDLINE | ID: mdl-19961961

RESUMO

In this study, we developed a novel DNA vaccine for HPV; a recombinant baculovirus bearing human endogenous retrovirus (HERV) envelope protein, which cannot replicate in mammals, was used as a nano-carrier for HPV-16L1 DNA vaccine (AcHERV-HP16L1). For in vivo test, mice were injected intramuscularly with 107 particles of the constructs, with two boosts at 2-week intervals. Compared with Gardasil (25 microL/dose), the AcHERV-HP16L1 immunized mice showed similar high levels of humoral immunity in IgG/IgA and in neutralization of HPV pseudovirions. Combined immunization (prime with AcHERV-HP16L1 and boost with Gardasil) induced slightly higher neutralizing activity. As compared to the group treated with Gardasil, the mice immunized with AcHERV-HP16L1 showed 450- and 490-fold increase in the IFN-gamma at 5 and 20 weeks after the first priming, respectively. The combined immunization conferred lower T cell immunity than AcHERV-HP16L1 treatment. The advantages of our novel AcHERV-HP16L1 vaccine over Gardasil include higher cellular immunogenicity, considerably lower production cost, and comparable safety. Therefore, we suggest that AcHERV-HP16L1 can be developed as an efficient prophylactic vaccine and therapeutic vaccine.


Assuntos
Proteínas do Capsídeo/imunologia , Proteínas de Transporte/metabolismo , Retrovirus Endógenos/genética , Proteínas Oncogênicas Virais/imunologia , Vacinas contra Papillomavirus/imunologia , Vacinas de DNA/imunologia , Proteínas do Envelope Viral/metabolismo , Animais , Anticorpos Neutralizantes/sangue , Anticorpos Antivirais/sangue , Proteínas do Capsídeo/genética , Proteínas de Transporte/genética , Feminino , Vacina Quadrivalente Recombinante contra HPV tipos 6, 11, 16, 18 , Imunização Secundária , Imunoglobulina A/sangue , Imunoglobulina G/sangue , Injeções Intramusculares , Interferon gama/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Proteínas Oncogênicas Virais/genética , Vacinas contra Papillomavirus/administração & dosagem , Vacinas contra Papillomavirus/genética , Linfócitos T/imunologia , Vacinação/métodos , Vacinas de DNA/genética , Proteínas do Envelope Viral/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...